New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily on a distinct "optimal...
Search results for "dementia drugs"
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects
A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound and light stimulation,...
“65% of Dementia-Causing Protein Removed Without Drugs” Could Ultrasound Offer New Hope?
A South Korean research team has succeeded in removing a key substance implicated in Alzheimer’s disease using...
"65% Reduction of Dementia-Causing Protein Without Drugs" Ultrasound, A New Hope?
A domestic research team has succeeded in removing the causative substances of Alzheimer's disease using ultrasound.
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports
GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are...
'2 Million Brain Cells Die Every Minute': Neurologists Call for National Strategy as South Korea Ages
"In a super-aged society, brain diseases represent a core healthcare challenge that the nation must tackle...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight
For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
1